To access this element change to forms mode OFF
Grant Award View - GA204229
A novel single treatment for two serious complications of allogeneic...
GA ID:
GA204229
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
3-Nov-2021
Publish Date:
6-Dec-2021
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2026
Value (AUD):
$1,863,376.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
A novel single treatment for two serious complications of allogeneic stem cell transplantation: acute graft-versus-host disease and sinusoidal obstruction syndrome.
Purpose:
Acute graft versus host disease (GVHD) is a frequent and devastating complication of allogeneic stem cell transplantation, which is the use of stem cells from a donor related or unrelated to the patient who is the recipient. It is mediated by immune activation and inflammation. We have developed a new drug (Anti-VCAM-CD39) that has anti-inflammatory and immune suppressive properties. We will test the efficacy of this drug to simultaneously treat GVHD.
GO ID:
GO Title:
2021 Ideas Grants
Internal Reference ID:
2021/GNT2011447
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Monash University
Recipient ABN:
12 377 614 012
Grant Recipient Location
Suburb:
Clayton
Town/City:
Clayton
Postcode:
3800
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, VIC
Postcode:
Multiple
Country:
AUSTRALIA